| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Increased metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure.
|
J Appl Physiol (1985)
|
2007
|
4.02
|
|
2
|
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.
|
Circulation
|
2003
|
3.89
|
|
3
|
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
|
Eur Heart J
|
2005
|
3.89
|
|
4
|
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
|
Eur Heart J
|
2016
|
3.83
|
|
5
|
Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.
|
Circulation
|
2002
|
3.34
|
|
6
|
Ethical authorship and publishing.
|
Int J Cardiol
|
2008
|
2.97
|
|
7
|
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
|
Eur J Heart Fail
|
2016
|
2.91
|
|
8
|
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope.
|
Eur Heart J
|
2005
|
2.84
|
|
9
|
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
|
Circulation
|
2002
|
2.71
|
|
10
|
Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle.
|
J Cachexia Sarcopenia Muscle
|
2010
|
2.49
|
|
11
|
Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
|
J Am Coll Cardiol
|
2004
|
2.29
|
|
12
|
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
|
J Am Coll Cardiol
|
2005
|
2.28
|
|
13
|
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
|
J Am Coll Cardiol
|
2009
|
2.20
|
|
14
|
The relationship between cholesterol and survival in patients with chronic heart failure.
|
J Am Coll Cardiol
|
2003
|
2.12
|
|
15
|
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
|
J Am Coll Cardiol
|
2012
|
2.11
|
|
16
|
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.
|
Lancet
|
2003
|
2.10
|
|
17
|
Top of the charts: download versus citations in the International Journal of Cardiology.
|
Int J Cardiol
|
2005
|
2.06
|
|
18
|
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.
|
J Am Coll Cardiol
|
2007
|
1.92
|
|
19
|
Statement on authorship and publishing ethics in the International Journal of Cardiology.
|
Int J Cardiol
|
2011
|
1.90
|
|
20
|
How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH.
|
Int J Cardiol
|
2002
|
1.83
|
|
21
|
Contemporary (post-Wills) survey of the views of Australian medical researchers: importance of funding, infrastructure and motivators for a research career.
|
Med J Aust
|
2005
|
1.79
|
|
22
|
Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study.
|
JAMA
|
2003
|
1.64
|
|
23
|
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
|
Circulation
|
2004
|
1.59
|
|
24
|
Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease.
|
Circulation
|
2002
|
1.58
|
|
25
|
Retracted
Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy.
|
N Engl J Med
|
2002
|
1.56
|
|
26
|
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.
|
J Card Fail
|
2003
|
1.54
|
|
27
|
Omapatrilat--the story of Overture and Octave.
|
Int J Cardiol
|
2002
|
1.49
|
|
28
|
The Research Quality Framework and its implications for health and medical research: time to take stock?
|
Med J Aust
|
2006
|
1.49
|
|
29
|
Advances in the non-drug, non-surgical, non-device management of chronic heart failure.
|
Int J Cardiol
|
2005
|
1.45
|
|
30
|
Patient descriptions of breathlessness in heart failure.
|
Int J Cardiol
|
2005
|
1.42
|
|
31
|
Retraction: Shamim et Al. Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy. N Engl J Med 2002;347:1326-33.
|
N Engl J Med
|
2003
|
1.40
|
|
32
|
Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis.
|
Eur J Heart Fail
|
2010
|
1.34
|
|
33
|
Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
|
J Am Coll Cardiol
|
2002
|
1.31
|
|
34
|
Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?
|
Int J Cardiol
|
2002
|
1.28
|
|
35
|
Exercise-based rehabilitation for heart failure.
|
Cochrane Database Syst Rev
|
2014
|
1.28
|
|
36
|
Muscle metaboreflex-induced increases in stroke volume.
|
Med Sci Sports Exerc
|
2003
|
1.18
|
|
37
|
Oscillatory ventilation during exercise in patients with chronic heart failure: clinical correlates and prognostic implications.
|
Chest
|
2002
|
1.16
|
|
38
|
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.
|
Eur Heart J
|
2004
|
1.13
|
|
39
|
Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease.
|
Am J Cardiol
|
2003
|
1.12
|
|
40
|
Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival.
|
Int J Cardiol
|
2004
|
1.11
|
|
41
|
Muscle wasting disease: a proposal for a new disease classification.
|
J Cachexia Sarcopenia Muscle
|
2014
|
1.10
|
|
42
|
The regulation and measurement of plasma volume in heart failure.
|
J Am Coll Cardiol
|
2002
|
1.09
|
|
43
|
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.
|
Am Heart J
|
2007
|
1.08
|
|
44
|
Albumin levels predict survival in patients with heart failure and preserved ejection fraction.
|
Eur J Heart Fail
|
2011
|
1.07
|
|
45
|
Congenital heart disease: the original heart failure syndrome.
|
Eur Heart J
|
2003
|
1.07
|
|
46
|
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
|
Eur Heart J
|
2013
|
1.06
|
|
47
|
A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy.
|
Eur J Heart Fail
|
2002
|
1.02
|
|
48
|
Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
|
J Med Virol
|
2004
|
1.00
|
|
49
|
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.
|
Eur J Heart Fail
|
2004
|
0.98
|
|
50
|
Chemical mediators of the muscle ergoreflex in chronic heart failure: a putative role for prostaglandins in reflex ventilatory control.
|
Circulation
|
2002
|
0.98
|
|
51
|
Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure.
|
Am J Cardiol
|
2002
|
0.97
|
|
52
|
Relationship between detrended fluctuation analysis and spectral analysis of heart-rate variability.
|
Physiol Meas
|
2002
|
0.96
|
|
53
|
Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot.
|
Circulation
|
2002
|
0.95
|
|
54
|
Exercise training in chronic heart failure: effects on pro-inflammatory markers.
|
Eur J Heart Fail
|
2005
|
0.95
|
|
55
|
Diuretics for heart failure.
|
Cochrane Database Syst Rev
|
2012
|
0.95
|
|
56
|
Skeletal muscle reflex in heart failure patients: role of hydrogen.
|
Circulation
|
2003
|
0.94
|
|
57
|
Sleep-disordered breathing in a general heart failure population: relationships to neurohumoral activation and subjective symptoms.
|
J Sleep Res
|
2006
|
0.93
|
|
58
|
Obesity paradox as a component of reverse epidemiology in heart failure.
|
Arch Intern Med
|
2005
|
0.93
|
|
59
|
Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure.
|
Am J Cardiol
|
2002
|
0.92
|
|
60
|
Differential contribution of dead space ventilation and low arterial pCO2 to exercise hyperpnea in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
|
Am J Cardiol
|
2004
|
0.92
|
|
61
|
Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker).
|
Int J Cardiol
|
2004
|
0.92
|
|
62
|
Impact of periodic breathing on measurement of oxygen uptake and respiratory exchange ratio during cardiopulmonary exercise testing.
|
Clin Sci (Lond)
|
2002
|
0.92
|
|
63
|
Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration.
|
Int J Cardiol
|
2002
|
0.91
|
|
64
|
Global impairment of cardiac autonomic nervous activity late after the Fontan operation.
|
Circulation
|
2003
|
0.91
|
|
65
|
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.
|
Int J Cardiol
|
2006
|
0.90
|
|
66
|
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue.
|
J Card Fail
|
2004
|
0.90
|
|
67
|
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha.
|
Int J Cardiol
|
2002
|
0.88
|
|
68
|
The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats.
|
J Cachexia Sarcopenia Muscle
|
2013
|
0.87
|
|
69
|
Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study.
|
Eur J Heart Fail
|
2011
|
0.87
|
|
70
|
The epidemiological enigma of heart failure with preserved systolic function.
|
Eur J Heart Fail
|
2004
|
0.86
|
|
71
|
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition.
|
Int J Cardiol
|
2008
|
0.86
|
|
72
|
Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS.
|
Eur J Heart Fail
|
2012
|
0.86
|
|
73
|
Echocardiography-derived variables predict outcome in patients with nonischemic dilated cardiomyopathy with or without a restrictive filling pattern.
|
Am Heart J
|
2002
|
0.86
|
|
74
|
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
|
Rev Esp Cardiol (Engl Ed)
|
2016
|
0.85
|
|
75
|
The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failure.
|
Int J Cardiol
|
2003
|
0.85
|
|
76
|
Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial.
|
Am Heart J
|
2003
|
0.85
|
|
77
|
The epidemiology of heart failure in Australia.
|
Int J Cardiol
|
2006
|
0.85
|
|
78
|
Adherence to ethical standards in publishing scientific articles: a statement from the International Journal of Cardiology.
|
Int J Cardiol
|
2012
|
0.85
|
|
79
|
Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins.
|
Eur J Heart Fail
|
2005
|
0.84
|
|
80
|
The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure.
|
Eur J Heart Fail
|
2005
|
0.84
|
|
81
|
The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty.
|
Int J Cardiol
|
2002
|
0.84
|
|
82
|
Haemoglobin concentration and prognosis in new cases of heart failure.
|
Lancet
|
2003
|
0.84
|
|
83
|
Relationship of skeletal muscle metaboreceptors in the upper and lower limbs with the respiratory control in patients with heart failure.
|
Clin Sci (Lond)
|
2002
|
0.83
|
|
84
|
Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes.
|
Eur J Heart Fail
|
2007
|
0.83
|
|
85
|
Beta-blocker therapy for dynamic left-ventricular outflow tract obstruction.
|
Int J Cardiol
|
2002
|
0.83
|
|
86
|
Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure.
|
Eur Heart J
|
2004
|
0.83
|
|
87
|
Effect of anemia on exercise tolerance in chronic heart failure in men.
|
Am J Cardiol
|
2003
|
0.82
|
|
88
|
Is central nervous system processing altered in patients with heart failure?
|
Eur Heart J
|
2004
|
0.81
|
|
89
|
Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure.
|
Eur J Heart Fail
|
2005
|
0.81
|
|
90
|
Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study.
|
Int J Cardiol
|
2004
|
0.81
|
|
91
|
Why ventilatory inefficiency matters in chronic heart failure.
|
Eur Heart J
|
2005
|
0.81
|
|
92
|
Abnormal temporal dynamics of blood pressure and RR interval regulation in patients with chronic heart failure: relationship to baroreflex sensitivity.
|
Int J Cardiol
|
2002
|
0.80
|
|
93
|
Reduced confounding by impaired ventilatory function with oxygen uptake efficiency slope and VE/VCO2 slope rather than peak oxygen consumption to assess exercise physiology in suspected heart failure.
|
Congest Heart Fail
|
2010
|
0.80
|
|
94
|
Influence of valve prosthesis type on the recovery of ventricular dysfunction and subendocardial ischaemia following valve replacement for aortic stenosis.
|
Int J Cardiol
|
2004
|
0.79
|
|
95
|
Reproducibility of the measurement of the muscle ergoreflex activity in chronic heart failure.
|
Eur J Heart Fail
|
2003
|
0.79
|
|
96
|
Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.
|
Int J Cardiol
|
2005
|
0.79
|
|
97
|
Variability of phase shift between blood pressure and heart rate fluctuations: a marker of short-term circulation control.
|
Circulation
|
2003
|
0.78
|
|
98
|
Exercise hyperventilation in chronic heart failure is not caused by systemic lactic acidosis.
|
Eur J Heart Fail
|
2005
|
0.78
|
|
99
|
Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.
|
Int J Cardiol
|
2002
|
0.78
|
|
100
|
Association of deranged adrenal steroid metabolism with anemia in chronic heart failure.
|
Am J Cardiol
|
2005
|
0.78
|
|
101
|
The cardiac component of cardiac cachexia.
|
Am Heart J
|
2002
|
0.78
|
|
102
|
MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
|
Int J Cardiol
|
2002
|
0.78
|
|
103
|
A noninvasive measure of baroreflex sensitivity without blood pressure measurement.
|
Am Heart J
|
2002
|
0.77
|
|
104
|
β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure.
|
Heart
|
2010
|
0.77
|
|
105
|
Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
|
Int J Cardiol
|
2013
|
0.77
|
|
106
|
Cellular endotoxin desensitization in patients with severe chronic heart failure.
|
Eur J Heart Fail
|
2005
|
0.76
|
|
107
|
Redefining heart failure.
|
Int J Cardiol
|
2006
|
0.76
|
|
108
|
Aerobic exercise physiology in a professional rugby union team.
|
Int J Cardiol
|
2003
|
0.76
|
|
109
|
Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC.
|
Eur J Heart Fail
|
2014
|
0.76
|
|
110
|
[2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].
|
Kardiol Pol
|
2016
|
0.76
|
|
111
|
Impact of sleep disordered breathing severity on hemodynamics, autonomic balance and cardiopulmonary functional status in chronic heart failure.
|
Int J Cardiol
|
2009
|
0.75
|
|
112
|
Human pituitary growth hormone and cancer risk.
|
Lancet
|
2002
|
0.75
|
|
113
|
Treatment of heart failure.
|
Hosp Med
|
2002
|
0.75
|
|
114
|
Heart failure: Support for exercise training in CHF.
|
Nat Rev Cardiol
|
2009
|
0.75
|
|
115
|
Ventricular long axis function is predictive of outcome in patients with chronic heart failure secondary to non-ischemic dilated cardiomyopathy.
|
Med Sci Monit
|
2003
|
0.75
|
|
116
|
Five years of progress for International Journal of Cardiology.
|
Int J Cardiol
|
2004
|
0.75
|
|
117
|
Retraction of "Song ZZ, Resynchronization of the infarcted myocardium. Int J Cardiol. 2009 Jan 9. [Epub ahead of print]" containing plagiarised material.
|
Int J Cardiol
|
2009
|
0.75
|
|
118
|
Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern.
|
Am J Cardiol
|
2003
|
0.75
|
|
119
|
Retraction of a paper containing plagiarized material: the prognostic value of serum troponin T in unstable angina. Gökhan Cin V, Gök H, Kaptanoğlu B. Int J Cardiol. 1996 Mar;53(3):237-44.
|
Int J Cardiol
|
2009
|
0.75
|
|
120
|
WITHDRAWN: Diuretics for heart failure.
|
Cochrane Database Syst Rev
|
2016
|
0.75
|
|
121
|
Adult congenital heart disease in the International Journal of Cardiology.
|
Int J Cardiol
|
2003
|
0.75
|
|
122
|
The top papers by download and citations from the International Journal of Cardiology in 2007.
|
Int J Cardiol
|
2008
|
0.75
|